Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748525 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02748525 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants.
The verdict
NCT02748525, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study aims to combine the use of IV CCK administration followed by oral milk during a HIDA scan to further stimulate the gallbladder contractility and decrease the number of false abnormal HIDA scans and unnecessary cholecystectomies in some patients.
Interventions
- OTHER Milk
- BIOLOGICAL CCK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-05-03 |
| Est. Completion | 2018-06-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02748525
The ClinicalTrials.gov registry entry for NCT02748525 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Milk is the first listed.
NCT02748525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02748525 about?
NCT02748525 is a clinical study titled "Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively". This study aims to combine the use of IV CCK administration followed by oral milk during a HIDA scan to further stimulate the gallbladder contractility and decrease the number of false abnormal HIDA scans and unnecessary cholecystectomies in some patients.
What is the current status of trial NCT02748525?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-05-03. Estimated completion is 2018-06-14.
What interventions are being tested in trial NCT02748525?
The interventions under investigation include: Milk (OTHER), CCK (BIOLOGICAL).
Who is sponsoring clinical trial NCT02748525?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.